PAGE TOP
Our Team

Our Team

Our Team

Management

Toshihiko Honkura, MBA (co-founder)

Toshihiko Honkura, MBA (co-founder)

President and CEO

A co-founder of Quantum Biosystems Inc., Toshihiko represents the company as both president and CEO. After a genome research project at the University of Tokyo, he went on to gain ten years’ hands-on experience in business management and investment analysis as a manager at McKinsey & Company and the Innovation Network Corporation of Japan (INCJ), a public-private Japanese fund. He has a master’s degree in Analytical Biochemistry from the University of Tokyo and an MBA from Columbia University. The scientific and business management acumen he brings to the team affords the company excellent and tested leadership.

Christopher Pascoe, CPA

Christopher Pascoe, CPA

Chief Financial Officer (CFO)

Chris has more than thirty years of experience in the biotechnology and software industries. He has been the founding CFO for several companies in these areas, and also has experience as COO at two biotechnology companies, most notably at Perlegen Sciences, a genetic analysis and diagnostic testing company based in California. He is a CPA (PricewaterhouseCoopers) and a Chartered Accountant (Deloitte), and brings to Quantum Biosystems his extensive international experience in establishing and managing strong financial and operational practices.

Yoshiaki Yoshikuni, Ph.D.

Yoshiaki Yoshikuni, Ph.D.

General Manager, Administration Department

Yoshiaki has fifty years experience of R&D in pharm/biotechnology and nutraceutical industries. He started as a researcher in Nippon Shinyaku Co., Ltd. after graduating from Kyoto University (Agricultural Chemistry) and held the position of general manager of Discovery Research Laboratories. His career in business development started when he was transferred to the head of the U.S. subsidiary. Five years of management experience in GMP manufacturing, FDA clinical trials, licensing and accounting helped further his career in biotechnology start-up companies including Oxigenix Co.,Ltd (Liposome-encapsulated Hemoglobin production, based in Kyoto), A-Cube, Inc.(Antibody design, based in California), and Pharma Eight Co.,Ltd.(Drug discovery, based in Kyoto). He has contributed to business development, capital-raising and other back-office operations in these companies as a board director and CFO.

Naonori Kurokawa, PhD/MBA

Naonori Kurokawa, PhD/MBA

External board director

Naonori is a partner at The University of Tokyo Edge Capital (UTEC) focusing on seed and early stage physical science and life science investments. He currently serves on the boards of high-tech startups including Microwave Chemical Co., Ltd. and ROCA K.K. His passion is to support and cooperate with academics and entrepreneurs who have industry-changing ideas. He earned his PhD in Applied Physics from Osaka University followed by an MBA from the University of Chicago Booth School of Business.

Katsuya Hashizume, MS

Katsuya Hashizume, MS

External board director

Katsuya Hashizume is a Senior Associate of the Academic-Corporate Liaison Investment Group at JAFCO CO., Ltd., the largest venture capital firm in Japan. He focuses on seed/early stage high-tech startups originated from universities or research institutes. He earned a master’s degree in Media and Governance (Research Field: Cyber Informatics) from Keio University.

Takehiko Sawabe, MS/MBA

Takehiko Sawabe, MS/MBA

External board director

Takehiko Sawabe is a vice president of Healthcare Team of Innovation Network Corporation of Japan (INCJ). He has extensive experience in pharmaceutical and biotechnology industries. He concurrently serves on the boards of several life science startups including Anaeropharma Science Inc., Stella Pharma Corporation., Scohia Pharma Inc., and, Megakaryon Corporation. He received a master’s degree in Pharmaceutical Science from the University of Tokyo and an MBA from Graduate School of Management, GLOBIS University.

Teruhisa Tajima, CPA

Teruhisa Tajima, CPA

External Auditor

Teruhisa has twenty years’ experience of business consultancy and auditing. He has worked at Pricewaterhouse Coopers and the Shimizu Patent Office as a consultant for start-ups, supporting their growth and successful emergence via M&A or IPOs. He is also an external auditor of The Longreach Group and CYBIRD Holdings Co., Ltd. In 2010, he established the Tajima Accounting Office. He has supported many biotechnology start-ups.

R&D

Eric Nordman

Eric Nordman

Eric worked twenty-eight years developing complex systems for genetic analysis at Applied Biosystems. Eric served as lead systems engineer for several generations of DNA sequencing instrumentation. He holds a number of patents in microfluidics, optics and capillary electrophoresis. In 2008 Eric was awarded the Distinguished Inventor Award from Applied Biosystems. Eric received his BS and MS from University of California, Berkeley.

Hisao Kawasaki, PhD

Hisao Kawasaki, PhD

Director of R&D

Having spent the last two decades working for Motorola in Austin, Texas as a Fellow of the Technical Staff and Manager of the Intrinsic Reliability Department, Hisao brings extensive experience in semiconductor process development and intrinsic reliability to the team. In addition to previous experience as Process Development Manager for Texas Instruments in Japan and as a Member of Technical Staff in the US, where he was engaged in multi-level metallization and silicide process development, he also has General Manager experience in the Process Development Department of a Mitsubishi Heavy Industries spin-off company. He has authored or co-authored over 90 journal and conference papers, and has 14 U.S. patents to his name. His doctorate in electronic engineering was awarded by Tohoku University.

Mark Oldham

Mark Oldham

Mark has more than 25 years experience in biotech instrument R&D with Applied Biosystems and several other Next Gen sequencing companies. As a systems engineer he specified, developed, and integrated biochemistry, electronics, mechanics, optics, firmware, and software for numerous projects involving Next Gen DNA sequencing, synchronous and asynchronous single molecule sequencing, nanopore and nano-channel detection, and sample preparation. Prior to working in Biotechnology he spent 10 years working in the semiconductor fabrication field. Mark has over 300 patent filings. In addition, he has expertise in the Next Gen IP landscape, drafting patents, and interacting with the U.S. Patent Office. Mark has degrees in electrical engineering and mathematics from San Jose State University in California.

Timothy M. Woudenberg, PhD

Timothy M. Woudenberg, PhD

Formally educated in Physical Chemistry, Tim has a 25+ year history in scientific instrument industry, working for large and small companies, driving the development of new technology. Highlights include proof of concept of real time qPCR, and approximately 30 U.S. patents. Typically you will find Tim at the laboratory bench where he confirms the observation of Louis Pasteur: “Luck favors the prepared mind”.

Jonathan Teutenberg, PhD

Jonathan Teutenberg, PhD

Jonathan holds a doctorate in Computer Science from the University of Auckland. His research has covered speech processing, machine learning and AI planning. Prior to joining Quantum Biosystems, Jonathan worked for two years as a Senior Computational Scientist with Oxford Nanopore in the areas of algorithm development and data analysis.

Val Dimitrov, PhD

Val Dimitrov, PhD

Val holds a doctorate in Electrical and Computer Engineering (ECE) from University of Illinois at Urbana-Champaign (UIUC). He has over ten years of experience developing biosensors and systems for single molecule detection and DNA mapping and sequencing. Val possesses a broad range of expertise: solid state device physics and high speed electronic circuits, micro- and nanofabrication, microfluidics, materials analysis, signal processing, data analysis and statistical modeling. Prior to joining Quantum Biosystems, Val lead a team that successfully developed a detector that was used for mapping medium size genomes.

Gaurav Goyal, PhD

Gaurav Goyal, PhD

Gaurav obtained his Ph.D. in Biomedical Engineering from Drexel University, Philadelphia and a master’s in Bioengineering from KAIST, South Korea. During the grad school, he obtained significant experience in micro/nano fabrication and use of solid-state nanopores for single-molecule DNA detection.

David Morris-Oliveros

David Morris-Oliveros

David has developed software, electronics and mechanical systems. He has a diverse background having earned his Bachelors in Spain and his Master of Science in Computing in Australia. He has mainly worked in the area of High Performance Computing (HPC) ranging from video games, 3D animation to live action movies developing and managing both software and hardware systems.

Koichi Makino

Koichi Makino

Koichi’s experience includes measuring technic for extreme region of electrical quantity as well as failure analysis for precision electrical measuring system at Keithley Instruments for ten years. In addition, Koichi contributed to building the local service department of Keithley and improving its performance as service manager. Prior to Keithley, he gained his experience for quality assurance and circuit design for jigs at Pioneer Corporation. He received his BSEE degree from University of Minnesota, Minneapolis.

Business team

Takeshi Akatsu, PhD, Patent Attorney

Takeshi Akatsu, PhD, Patent Attorney

Takashi has some ten years’ experience in materials science as a researcher at the Max Planck Institutes of Metal Research and Microstructure Physics (Germany) and as an R&D project leader for advanced substrate development at SOITEC (France). In Japan, he worked in IP law firms. He therefore brings a profound knowledge of R&D and IP to his role as director of IP and BD at Quantum Biosystems. He was awarded a doctorate in Precision Machinery Engineering by the University of Tokyo.

Masau Takayanagi, Patent Attorney

Masau Takayanagi, Patent Attorney

Masau has more than forty years’ experience in IP management. In 2012, he established Takayanagi IP Management after working as an executive officer and director of IP at Kyowa Kirin. He is also a representative of the Licensing Executives Society Japan and teaches classes focused on pharmaceutical IP at several universities in Japan. He was an executive board member and head of the IP Department at Mitsubishi Pharma Corporation and a vice chairman of the Japan Pharmaceutical Manufacturers Association (JPMA) Intellectual Committee.

Akira Usui

Akira Usui

Akira has more than twenty years’ experience of licensing, business development and alliance management in the pharmaceutical industry. He worked at Roche as a director of business development in the Pharmaceutical Division, mainly focused on the Asia-Pacific region, and established Roche Pharma’s Japan office. He was also representative director and general manager at Perlegen Sciences Japan and a vice president at its parent company in the US. Pergelen was established to identify patterns of genetic variation between individuals, information which was then used to improve patient care and discover the genetic foundations of diseases. In 2007, he founded Ray Life Sciences Inc., and he has worked as an external board director for a number of biotechnology venture companies.

Li Jin Sajo

Li Jin Sajo

Li conducted research on DNA methylation in the Department of Pharmaceutical Science at the University of Tokyo’s Graduate School. Quantum Biosystems utilizes his technical knowledge in this field. He has also worked with clients in the pharmaceutical industry as a consultant at McKinsey & Company. He is currently pursuing an MBA at Stanford’s Graduate School of Business.

Takuma Nakatsuka

Takuma Nakatsuka

Takuma has extensive management experience in pharma/ biotechnology industries, including as CFO of NanoCarrier (DDS/nanotechnology), AnGes-MG (gene therapy) and Nihon-Schering, as well as CEO of GenoMedia (gene therapy). He also has over 15 years of management experience in manufacturing and service industries such as Hosokawa Micron (nanotechnology), Veolia-Water Japan and Nishihara Environment Technology (engineering). His career started in public service right after graduation from the University of Tokyo (law). His graduate studies were in public policy and economics at the University of Michigan before he was awarded an MBA (finance and strategic management) from Wharton School, the University of Pennsylvania.

Scientific Advisors

Tomoji Kawai, PhD

Tomoji Kawai, PhD

Tomoji is our senior scientific advisor. A specially appointed professor at the Institute of Scientific and Industrial Research, Osaka University (ISIR), Tomoji’s specialty is single-molecule analysis technology. He is the lead researcher on the Kawai Project, formally known as Research and Development of Innovative Nanobiodevices based on Single-molecule Analysis, which receives governmental support from the FIRST program. The Japanese government has invested thirty million dollars in the FIRST Kawai Project since 2009. The single-molecule analysis technology of this project is the core technology of Quantum Biosystems. Tomoji was awarded his doctorate in Chemistry by the Department of Science at the Graduate School of the University of Tokyo.

The Institute of Scientific and Industrial Research, Osaka University

Yoshinobu Baba, PhD

Yoshinobu Baba, PhD

Yoshinobu is a professor at the Graduate School of Engineering at Nagoya University. He is one of the foremost experts on nanobiodevices, and is involved in multiple projects in Japan at the national level. He is also chairman of Nagoya University’s FIRST Research Center for Innovative Nanobiodevices and of its Synchrotron Radiation Research Center. He is co-creator of the FIRST-sponsored Kawai Project (Research and Development of Innovative Nanobiodevices based on Single-molecule Analysis), and, concurrently, executive committee chairman of Nanobio Expo. He was awarded his doctorate in Chemistry by the Faculty of Science at the Graduate School of Kyushu University.

Baba Laboratory, Nagoya University

Massimiliano Di Ventra, PhD

Massimiliano Di Ventra, PhD

Massimiliano is a professor at the University of California, San Diego. He is a world-renowned theorist in condensed matter physics. He was the first to propose and support the sequencing by tunneling concept, a core idea behind both the FIRST Project and Quantum Biosystems. His team at the University of California has theoretically shown the feasibility of this fast, inexpensive technique to sequence DNA as it passes through nanopores. He was awarded his doctorate by the Swiss Federal Institute of Technology in Lausanne (Ecole polytechnique federale de Lausanne).

Department of Physics, UC San Diego

Latha Venkataraman, PhD

Latha Venkataraman, PhD

Latha Venkataraman received her Bachelor’s degree in Physics from Massachusetts Institute of Technology in 1993 where she did her undergraduate thesis with Prof. Mildred Dresselhaus. She then moved to Harvard University and obtained her Ph. D. in 1999 working under the guidance of Prof. Charles Lieber. She worked as a research scientist at Vytran Corporation from 1999 to 2002. In 2003, she joined Columbia University as a research scientist. She started her independent career as an assistant professor in the Department of Applied Physics and Applied Mathematics at Columbia University in 2007.Prominent awards she has received include the National Science Foundation Career Award, Packard Fellowship for Science and Engineering, and the Alfred P. Sloan Fellowship in Chemistry.

Latha Venkataraman, Department of Applied Physics and Department of Chemistry, Columbia University